CLOSE X

LUPIN LTD.

NSE : LUPINBSE : 500257ISIN CODE : INE326A01037Industry : Pharmaceuticals & DrugsHouse : Lupin
BSE1617.8519.65 (+1.23 %)
PREV CLOSE ( ) 1598.20
OPEN PRICE ( ) 1600.45
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 9186
TODAY'S LOW / HIGH ( )1594.75 1625.00
52 WK LOW / HIGH ( )628.1 1703.8
NSE1616.8016.85 (+1.05 %)
PREV CLOSE( ) 1599.95
OPEN PRICE ( ) 1611.00
BID PRICE (QTY) 1616.80 (7655)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 865183
TODAY'S LOW / HIGH( ) 1593.10 1625.00
52 WK LOW / HIGH ( )628 1704.25
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 01-03 1983
Management Info
Manju D Gupta - Chairman Nilesh Gupta - Managing Director
Registered Office

Address Kalpataru Inspire, 3rd Floor,Off. Western Express Highway,Santacruz (East),
Mumbai,
Maharashtra-400055

Phone 022 66402323

Email info@lupin.com

Website www.lupin.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS
23Mar Lupin gets nod to transfer trade gener
Lupin has received approval for the proposal to transfer its trade gener..
22Mar Lupin informs about closure of trading
Lupin has informed that in terms of SEBI (Prohibition of Insider Trading..
19Mar Lupin informs about stop transfer
Lupin has informed that it enclosed the details of share certificate, re..
18Mar Lupin informs about change in manageme
Lupin has informed about the appointment of Christoph Funke as Chief Tec..
15Mar USFDA completes inspection at Lupin’s
United States Food & Drug Administration (USFDA) has inspected Lupin..
Financials
in Millions
QTR Dec 23 ANNUAL 23
Net Profit9164.44252.1
Gross Profit 10839.6 5271.4
Operating Profit 1240511739.2
Net Sales 41157.5112588.3
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
up  26946.00 (0.74%)
M.Cap ( in Cr)57258.37
Sanofi India (BSE)
up  8118.25 (2.06%)
M.Cap ( in Cr)18696.83
Dr. Reddy's Lab (BSE)
up  6155.15 (1.78%)
M.Cap ( in Cr)102679.14
Divi's Lab (BSE)
up  3436.75 (2.14%)
M.Cap ( in Cr)91234.91
Glaxosmithkline Phar (BSE)
up  1943.10 (3.26%)
M.Cap ( in Cr)32917.29
Shareholding Pattern
PROMOTERS 47.04%
MUTUAL FUNDS/UTI 18.92%
FI/BANKS/INSURANCE 9.84%
NON-INSTITUTION 7.11%
GOVERNMENT 0.01%
FII 0%
Mf Holdings
Scheme NameHold(%)
Tata India Pharma & Healthcare Fund-Reg(G)11.20
Nippon India Pharma Fund(G)7.78
DSP Healthcare Fund-Reg(G)7.14
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)5.90
Nippon India Nifty Pharma ETF5.66
ICICI Pru Nifty Pharma Index Fund-Reg(G)5.65
ICICI Pru Nifty Healthcare ETF4.86
Investor Alert
1) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. 2) For Stock Broking Transaction 'Prevent unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day...Issued in the interest of Investors. 3) For Depository Transaction 'Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL/NSDL on the same day...Issued in the interest of investors. 4) No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. 5) Investors should be cautious on unsolicited emails and SMS advising to buy, sell or hold securities and trade only on the basis of informed decision. Investors are advised to invest after conducting appropriate analysis of respective companies and not to blindly follow unfounded rumours, tips etc. Further, you are also requested to share your knowledge or evidence of systemic wrongdoing, potential frauds or unethical behaviour through the anonymous portal facility provided on BSE & NSE website. 6) This is to inform that we B N Rathi securities Ltd not required to have a Business Continuity/DR plan under the existing regulatory provisions.

Prevent Unauthorised transactions in your Trading/Demat Account. Update your mobile numbers/email IDs with your stock brokers/DP. Receive information of your transactions directly from Exchanges/Depositories on your mobile/email at the end of the day. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account......Issued in the interest of investors. SEBI Circular - Investor Grievance Redress Mechanism - New Policy Measures. Kindly refer at Policies.

KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account

REGISTRATION NOS: SEBI Registration No: INZ000160834 (BSE-3233 | NSE-07141| MCX-56475) CDSL : SEBI Regn No. IN-DP-612-2021. AMFI-Registered Mutual Fund Distributor: B.N.Rathi Securities Ltd - ARN-77516: (B.N.Rathi is just acting as distributor. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism.) CIN: L65993TG1985PLC005838
In case of member having a website, member has created awareness amongst clients / investors with regard to procedure of pledge/ re-pledge of securities and displayed the guidelines on the homepage of their respective websites at a prominent place as required in Exchange circular ref no. NSE/INSP/45565 dated Sep 02,2020 Trading members had displayed the set of standard documents/policies on their own website for information.

Copyright 2021 © B.N.Rathi Securities Ltd - All Rights Reserved

Designed, Developed & Content Powered by Accord Fintech Pvt. Ltd.

CLOSE SEBI